Riskpilot← Back to searchSign inGet full accessARENDAL ØYELEGESENTER AS
ASActiveOrg 923930159Stoaveien 5B, 4848 ArendalGeneral medical practice activities · NACE 8621Est. 20197 employees
Revenue 2024
NOK 7,8M
-11% vs 2023
EBITDA margin
0.1%
-93% vs 2023
Equity ratio
15.1%
Financial strength
Net profit 2024
NOK -35K
-321% vs 2023
| Revenue | NOK 7,8M | -11% |
| EBITDA | NOK 4K | -93% |
| Net profit | NOK -35K | -321% |
| Total assets | NOK 1,2M | +0% |
| Equity | NOK 184K | -16% |
| Employees | 7 | — |
Legal name
ARENDAL ØYELEGESENTER AS
Org number
923930159
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
26. november 2019
Share capital
NOK 30 000
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter. Investering i andre selskaper og alt som står i forbindelse med dette.
Address
Stoaveien 5B, 4848 Arendal
Phone
+4737030500
Email
post@arendaloyelege.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 720 | 6 414 | 8 442 | 8 744 | 7 816 |
| Staff expenses | −2 027 | −3 288 | −4 437 | −4 744 | −3 676 |
| EBITDA | 112 | 40 | 42 | 66 | 4 |
| Depreciation & amort. | −0 | −0 | −21 | −46 | −39 |
| EBIT | 112 | 40 | 20 | 20 | −35 |
| Net financials | 0 | −0 | −0 | −0 | −7 |
| Profit before tax | 112 | 40 | 20 | 20 | −42 |
| Tax | 25 | 9 | 5 | 4 | −7 |
| Net profit | 88 | 31 | 15 | 16 | −35 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 685 | 778 | 1 146 | 1 224 | 1 219 |
| Equity | 128 | 188 | 203 | 219 | 184 |
| Long-term debt | 0 | 0 | 5 | 7 | 0 |
| Short-term debt | 558 | 590 | 938 | 998 | 1 035 |
| Total debt | 558 | 590 | 943 | 1 006 | 1 035 |
EBITDA margin
0.1%
This company
15.8%
Market median
-99% vs market
20202024
Equity ratio
15.1%
This company
38.2%
Market median
-60% vs market
20202024
Return on equity
-18.8%
This company
18.4%
Market median
-202% vs market
20202024
Net profit margin
-0.4%
This company
8.1%
Market median
-105% vs market
20202024
Asset turnover
6.41×
This company
1.12×
Market median
+472% vs market
20202024
Debt / equity
5.62×
This company
0.62×
Market median
-806% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Mare Holding As
ARENDAL ØYELEGESENTER AS Board members of ARENDAL ØYELEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Siv Tone Johansen | Board of Directors | 0 companies |
| Thor Egeberg | Board of Directors | 0 companies |
| Erlend Sødal | Chairman | 0 companies |
| Sigmund Jan Birkeland | Board of Directors | 0 companies |